Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia

Published:2015-03-10 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Buchner Maike,Park Eugene,Geng Huimin,Klemm Lars,Flach Johanna,Passegué Emmanuelle,Schjerven Hilde^ORCID,Melnick Ari,Paietta Elisabeth,Kopanja Dragana,Raychaudhuri Pradip,Müschen Markus

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms7471.pdf

Reference62 articles.

1. Chen, X. et al. The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism. Mol. Cell. Biol. 33, 227–236 (2013) .

2. Chen, Y. J. et al. A conserved phosphorylation site within the forkhead domain of FoxM1B is required for its activation by cyclin-CDK1. J. Biol. Chem. 284, 30695–30707 (2009) .

3. Laoukili, J. et al. Activation of FoxM1 during G2 requires cyclin A/Cdk-dependent relief of autorepression by the FoxM1 N-terminal domain. Mol. Cell. Biol. 28, 3076–3087 (2008) .

4. Park, H. J. et al. An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle. Oncogene 27, 1696–1704 (2008) .

5. Wang, I. C. et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol. Cell. Biol. 25, 10875–10894 (2005) .

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABL1-mediated phosphorylation promotes FOXM1-related tumorigenicity by Increasing FOXM1 stability;Cell Death & Differentiation;2024-07-26

2. Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer;Breast Cancer Research;2023-06-27

3. Targeting ROS-induced osteoblast senescence and RANKL production by Prussian blue nanozyme based gene editing platform to reverse osteoporosis;Nano Today;2023-06

4. The discrete roles of individual FOXO transcription factor family members in B-cell malignancies;Frontiers in Immunology;2023-05-18

5. The role of FoxM1 in immune cells;Clinical and Experimental Medicine;2023-03-13